Neoantigen-based peptide vaccine: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Neoantigen-based peptide vaccine

• Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
  NCT06751914 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
  NCT06751966 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve Neoantigen-based peptide vaccine?

2 recruiting trials across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.